↓ Skip to main content

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

Overview of attention for article published in BMC Cancer, September 2019
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
Published in
BMC Cancer, September 2019
DOI 10.1186/s12885-019-6121-3
Pubmed ID
Authors

R. de Haan, E. van Werkhoven, M.M. van den Heuvel, H. M. U. Peulen, G. S. Sonke, P. Elkhuizen, M. W. M. van den Brekel, M. E. T. Tesselaar, C. Vens, J. H. M. Schellens, B. van Triest, M. Verheij

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2019.
All research outputs
#12,083,752
of 13,612,446 outputs
Outputs from BMC Cancer
#4,145
of 5,101 outputs
Outputs of similar age
#175,084
of 211,021 outputs
Outputs of similar age from BMC Cancer
#1
of 1 outputs
Altmetric has tracked 13,612,446 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,101 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,021 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them